Experience of respiratory fluorohinolonum laevofloxacine application («Floracid®») in patients with non-severe community-acquired pneumonia

The dynamics of clinical and laboratory parameters in patients with community-acquired pneumonia were studied during the treatment with respiratory fluorohinolonum laevofloxacin «Floracid®». The high efficiency and safety of «Floracid®» were revealed during the research.